Sign In
NewsRadar

Mission Therapeutics

The company is developing a platform of technologies for the discovery and development of modulators of enzymes involved in cancer and other diseases.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 

Phone:
Web:
Contact:
 
 
Meditrina (Building 260)
Babraham Research Campus
Cambridge CB22 3AT
United Kingdom
+ 44 (0)1223 497454
http://missiontherapeutics.com
Niall Martin
+ 44 (0)1223 497454

Company Facts
Founded:Dec 2010
Founders:Niall Martin , Steve Jackson, Xavier Jacq, Keith Menear
CEO:Niall Martin
CTO or technical lead:Steve Jackson
CFO or finance director:
Head of Sales:
Head of Marketing:

Stage:
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:
Profitability:
Funding raised:Yes
Funding sought:
Seeking Partnerships:

Non-executive Board Members

Key Customers

Key Business Partners

Key Competitors

Capital Raised
DateSizeInvestors
To view this information you must be signed in and subscribed to the online dataservice, sign in here.

To read more about the Online data service click here

Public Offerings
DateTypeExchange
No public offerings


Data


24,839
Tech investments
From our Online Data Service
16,069
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Oct 13€2.8MBusiness applications
Oct 11€13.0MGames
Oct 11€10.0MSecurity
Oct 9€17.3MPayment software
Oct 9€5.0MSecurity
Oct 5€23.0MInternet commerce
Oct 5€6.1MSecurity

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase

Jan 2
Urban Jungle
urban jungle raises 1m in seed funding to build tech-enabled home ...

Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom





About usContact usLegal Information
Copyright 1999-2018
Emerging Technology Research Europe Inc. All rights reserved.